Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Shares Outstanding (Weighted Average) (2016 - 2025)

Apyx Medical (APYX) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $41.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 15.62% year-over-year to $41.1 million, compared with a TTM value of $41.1 million through Dec 2025, up 15.62%, and an annual FY2025 reading of $41.1 million, up 15.62% over the prior year.
  • Shares Outstanding (Weighted Average) was $41.1 million for Q4 2025 at Apyx Medical, up from $35.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $41.1 million in Q4 2025 and bottomed at $34.3 million in Q4 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $36.0 million, with a median of $34.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) rose 0.31% in 2023, then grew 15.62% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $34.3 million in 2021, then grew by 0.54% to $34.5 million in 2022, then increased by 0.31% to $34.6 million in 2023, then grew by 2.66% to $35.5 million in 2024, then rose by 15.62% to $41.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for APYX at $41.1 million in Q4 2025, $35.5 million in Q4 2024, and $34.6 million in Q4 2023.